Proteocyte AI is a molecular diagnostics company focused on predicting the risk of developing cancer through its innovative platform. The company identifies specific protein biomarkers that work in conjunction with proprietary algorithms, advanced imaging, and digital pathology. Their flagship product, Straticyte™, is designed to predict the progression of pre-malignant lesions to invasive oral cancer, enabling healthcare professionals to customize patient management and improve outcomes. Founded in 2011, Proteocyte aims to provide healthcare professionals with objective and quantifiable information to enhance patient care and reduce cancer incidence globally.
Something looks off?